Skip to main content

Site notifications

ICH M7(R2) Guideline on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk

We have adopted this International Scientific Guideline - ICH M7 (R2); EMA/CHMP/ICH/83812/2013

Last updated

Help us improve the Therapeutic Goods Administration site